Sequencing Therapies in the Third-Line and Beyond Setting for MCL
A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL.
Stay updated with breaking news from Sequencing Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL.
Laurie Sehn, MD, and Bijal Shah, MD, discuss remaining unmet needs for patients with relapsed/refractory FL.
Peter Martin, MD, discusses how to sequence bispecific T-cell engagers and CAR T-cell therapies in the third-line and beyond setting for FL.
Expert oncologists Laurent Greiller, MD, and Christian Grohé, MD, reflect on the current state of second-line treatment options for patients with small cell lung cancer.
Panelists share a brief discussion on the current treatment armamentarium available to patients with newly diagnosed multiple myeloma.